drugset / Trial / NCT02452060

Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy

NCT02452060

Phase 2/3 Completed 90 enrolled NYU Langone Health
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmission visit prior to surgery.

Timeline

Start
2014-10
Primary completion
2017-04-13
Completion
2017-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.4 mg/kg Intravenous

Indications

No indication recorded.